| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/23/2002 | WO2002040144A1 Method for making granules |
| 05/23/2002 | WO2002040083A2 Transcutaneous delivery means |
| 05/23/2002 | WO2002040062A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | WO2002040056A2 Carrageenan viscoelastics for ocular surgery |
| 05/23/2002 | WO2002040055A2 Solutions and films of glycated chitosan |
| 05/23/2002 | WO2002040054A1 Pharmaceutical preparation containing copolyvidone |
| 05/23/2002 | WO2002040053A1 Pharmaceutical preparation containing talc/barium sulfate |
| 05/23/2002 | WO2002040045A2 Microspheres of pancreatic enzymes with high stability |
| 05/23/2002 | WO2002040039A2 In vivo use of water absorbent polymers |
| 05/23/2002 | WO2002040033A1 Formulation containing phosphate derivatives of electron transfer agents |
| 05/23/2002 | WO2002040031A1 Adhesive preparation containing estradiol |
| 05/23/2002 | WO2002040029A2 Corticosteroids adducts with natural polysaccharide polymers |
| 05/23/2002 | WO2002040028A1 Antibacterial gel eye drops |
| 05/23/2002 | WO2002040021A2 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/23/2002 | WO2002040011A1 Process for producing drug granules containing branched amino acids |
| 05/23/2002 | WO2002040010A1 Nateglinide-containing hydrophilic drug preparations |
| 05/23/2002 | WO2002040003A1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 05/23/2002 | WO2002040001A2 Compositions for treatment of malignant effusions comprising a biocompatible polymer and antineoplastic taxane |
| 05/23/2002 | WO2002039998A2 Methods and compositions for regulating memory consolidation |
| 05/23/2002 | WO2002039993A2 Pharmaceutival preparations comprising corticosteroids and antiinfective agents |
| 05/23/2002 | WO2002039992A2 Adducts of quinolonic agents with natural polysaccharide polymers |
| 05/23/2002 | WO2002039986A1 Process for producing microparticles |
| 05/23/2002 | WO2002039985A1 Parenterally administrable microparticles |
| 05/23/2002 | WO2002039984A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 05/23/2002 | WO2002039983A2 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 05/23/2002 | WO2002039981A1 Microgranules based on active principle and method for making same |
| 05/23/2002 | WO2002039980A2 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole |
| 05/23/2002 | WO2002039979A1 Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles |
| 05/23/2002 | WO2002039978A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/23/2002 | WO2002039977A2 A method for restoring a foot fat-pad |
| 05/23/2002 | WO2002039963A1 Antifungal nail composition and method of use |
| 05/23/2002 | WO2002039955A2 Biodegradable mixed polymeric micelles for drug delivery |
| 05/23/2002 | WO2002039879A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002039832A1 Use of lactitol for improving intestinal microflora |
| 05/23/2002 | WO2002034267A8 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 05/23/2002 | WO2002015903A3 Novel pharmaceutical composition for administering n-0923 |
| 05/23/2002 | WO2002003970A3 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 05/23/2002 | WO2002003969A3 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 05/23/2002 | WO2001097749A3 The use of synthetic, non-hormonal 21-aminosteroids and thereof |
| 05/23/2002 | WO2001093846A3 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
| 05/23/2002 | WO2001093701A3 Aqueous chondroprotective compositions having defined ph limitations for efficacious delivery |
| 05/23/2002 | WO2001091720A3 Preparation of injectable suspensions having improved injectability |
| 05/23/2002 | WO2001089494A3 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases |
| 05/23/2002 | WO2001087284A3 Aldosterone antagonist composition for release during aldosterone acrophase |
| 05/23/2002 | WO2001087274A3 Plaster cover for children |
| 05/23/2002 | WO2001083513A3 Antisense modulation of inhibitor of dna binding-1 expression |
| 05/23/2002 | WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions |
| 05/23/2002 | WO2001082895A3 Guaifenesin sustained release formulation and tablets |
| 05/23/2002 | WO2001080828A3 Improved water-insoluble drug particle process |
| 05/23/2002 | WO2001078692A3 Membrane delivery system |
| 05/23/2002 | WO2001078660A3 Topical micronutrient delivery system and uses thereof |
| 05/23/2002 | WO2001049304A3 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 05/23/2002 | WO2001049273A3 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2001035941A3 Novel composition based on a thiazolidinedione and metformin and use |
| 05/23/2002 | WO2001035931A3 A film, sheet or wafer-shaped administration |
| 05/23/2002 | WO2000071121A9 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/23/2002 | US20020062125 Method of drug delivery to interstitial regions of the myocardium |
| 05/23/2002 | US20020062102 Electrodes and method for manufacturing electrodes for electrically assisted drug delivery |
| 05/23/2002 | US20020061932 Pharmaceutical composition |
| 05/23/2002 | US20020061931 <.5% of a corresponding lactam and > 20 ppm of an anion of a mineral acid, and after one year of storage at 25 degrees C. and 60% humidity conversion to the lactam doesn't exceed .2% |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061907 Macrolide compound, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener; topical for skin disorders |
| 05/23/2002 | US20020061906 Aerosol compositions |
| 05/23/2002 | US20020061884 And from 50 to 99% by weight of a vegetable oil selected from olive oil, peanut oil, soybean oil, corn oil, safflower oil, sunflower oil, canola oil, or walnut oil |
| 05/23/2002 | US20020061873 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component, and a surfactant |
| 05/23/2002 | US20020061870 Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
| 05/23/2002 | US20020061864 Antiseptic spermicidal composition and means for its application |
| 05/23/2002 | US20020061852 Methods of therapy with thrombin derived peptides |
| 05/23/2002 | US20020061838 Peptide pharmaceutical formulations |
| 05/23/2002 | US20020061592 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/23/2002 | US20020061349 Method and apparatus for coating solid centers |
| 05/23/2002 | US20020061340 Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
| 05/23/2002 | US20020061338 Solid preparation for dialysis and process for producing the same |
| 05/23/2002 | US20020061336 Also comprising a hydrogel, for use in the treatment of a subject by particle injection |
| 05/23/2002 | US20020061335 Powdered/microfibrillated cellulose |
| 05/23/2002 | US20020061334 Comprising mixture of particles of first composition containing electrolytes selected from sodium, calcium, magnesium, potassium chlorides and sodium acetate, particles of second composition containing sugar and above electrolytes |
| 05/23/2002 | US20020061333 Macrolide is not coated, is present in base form and is chosen from pristinamycin, azithromycin and clarithromycin, and contains at least one disintegrant |
| 05/23/2002 | US20020061332 Drug tablets having minimal "burst effect" and a more linear drug release profile over an extended period of time |
| 05/23/2002 | US20020061331 Bilayer structure which encapsulates multiple containment units and uses thereof |
| 05/23/2002 | US20020061327 Implanting capsule periocularly, capsule comprising core containing cellular source of biologically active molecule and a surrounding biocompatible jacket, jacket permitting diffusion of biologically active molecule into eye |
| 05/23/2002 | US20020061321 Film-forming polymer and at least one water-superabsorbent polymer in the form of water-swelled particles having a mean size of at least about 0.5 mm |
| 05/23/2002 | US20020061317 Therapeutic placebo enhancement of commonly-used medications |
| 05/23/2002 | US20020061314 Administering to animal live vaccine containing organisms to develop immunological response, maintaining animal free from drugs effective against infectious organism for period of one life or infectious cycle of organism, administering drug |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/23/2002 | US20020061288 Gels and multilayer surface structures from boronic acid containing polymers |
| 05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/23/2002 | US20020059939 Device and method for the cessation of smoking |
| 05/23/2002 | US20020059932 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 05/23/2002 | DE10058119A1 Pharmaceutical kit containing repinotan, for use in acute treatment of neurological disorders such as stroke, including assay composition for determining body repinotan levels to optimize dosage |
| 05/23/2002 | DE10056104A1 Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts |
| 05/23/2002 | CA2650698A1 Copolyvidone-containing preparation |
| 05/23/2002 | CA2431651A1 Antifungal nail composition and method of use |
| 05/23/2002 | CA2429103A1 Process for producing microparticles |
| 05/23/2002 | CA2429100A1 Parenterally administrable microparticles |
| 05/23/2002 | CA2429047A1 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | CA2428997A1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | CA2428837A1 Microspheres of pancreatic enzymes with high stability |